Introduction to radiobiology of targeted radionuclide therapy

Frontiers in Medicine

Volumn 2, Issue MAR, 2015, Pages 12-

  Pouget, Jean Pierre ^a,b,c   Lozza, Catherine ^a,b,c   Deshayes, Emmanuel ^a,b,c   Boudousq, Vincent ^a,b,c   Navarro Teulon, Isabelle ^a,b,c  

^a INSTITUT DE RECHERCHE EN CANCÉROLOGIE DE MONTPELLIER   (France)

^b UNIV MONTPELLIER   (France)

^c CENTRE VAL D AURELLE   (France)

Author keywords

Bystander effects; Radiobiology; Radioimmunotherapy; Targeted radionuclide therapy

Indexed keywords

EID: 85061995607     PISSN: None     EISSN: 2296858X     Source Type: Journal    
DOI: 10.3389/fmed.2015.00012     Document Type: Review

References (108)

1. Despeignes V. Observation concernant un cas de cancer de l'estomac traité par les rayons Roentge. In: Lyon Medical Lyon: Librairie Médicale de Louis Savy (1896). p. 428-30; 503-6.
2. Foray N. [Claudius Regaud (1870-1940): a pioneer of radiobiology and radiotherapy]. Cancer Radiother (2012) 16(4):315-21. doi: 10.1016/j.canrad.2012.05.006
3. Wang CK. The progress of radiobiological models in modern radiotherapy with emphasis on the uncertainty issue. Mutat Res (2010) 704(1-3):175-81. doi:10.1016/j.mrrev.2010.02.001
4. Cadet J, Ravanat JL, TavernaPorro M, Menoni H, Angelov D. Oxidatively generated complex DNA damage: tandem and clustered lesions. Cancer Lett (2012) 327(1-2):5-15. doi:10.1016/j.canlet.2012.04.005
5. Riley PA. Free radicals in biology: oxidative stress and the effects of ionizing radiation. Int J Radiat Biol (1994) 65(1):27-33. doi:10.1080/09553009414550041
6. Hamada N, Maeda M, Otsuka K, Tomita M. Signaling pathways underpinning the manifestations of ionizing radiation-induced bystander effects. Curr Mol Pharmacol (2011) 4(2):79-95. doi:10.2174/1874467211104020079
7. Droge W. Free radicals in the physiological control of cell function. Physiol Rev (2002) 82(1):47-95. doi:10.1152/physrev.00018.2001
8. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med (2010) 49(11):1603-16. doi:10.1016/j.freeradbiomed.2010.09.006
9. Hei TK, Zhou H, Chai Y, Ponnaiya B, Ivanov VN. Radiation induced non-targeted response: mechanism and potential clinical implications. Curr Mol Pharmacol (2011) 4(2):96-105. doi:10.2174/1874467211104020096
10. Hei TK, Zhou H, Ivanov VN, Hong M, Lieberman HB, Brenner DJ, et al. Mechanism of radiation-induced bystander effects: a unifying model. J Pharm Pharmacol (2008) 60(8):943-50. doi:10.1211/jpp.60.8.0001
11. Zhou H, Ivanov VN, Lien YC, Davidson M, Hei TK. Mitochondrial function and nuclear factor-kappaB-mediated signaling in radiation-induced bystander effects. Cancer Res (2008) 68(7):2233-40. doi:10.1158/0008-5472.CAN-07-5278
12. Matsumoto H, Tomita M, Otsuka K, Hatashita M, Hamada N. Nitric oxide is a key molecule serving as a bridge between radiation-induced bystander and adaptive responses. Curr Mol Pharmacol (2011) 4(2):126-34. doi:10.2174/1874467211104020126
13. Cadet J, Loft S, Olinski R, Evans MD, Bialkowski K, Richard Wagner J, et al. Biologically relevant oxidants and terminology, classification and nomenclature of oxidatively generated damage to nucleobases and 2-deoxyribose in nucleic acids. Free Radic Res (2012) 46(4):367-81. doi:10.3109/10715762.2012.659248
14. Pouget JP, Mather SJ. General aspects of the cellular response to low- and high-LET radiation. Eur J Nucl Med (2001) 28(4):541-61. doi:10.1007/s002590100484
15. Goodhead DT. Initial events in the cellular effects of ionizing radiations: clustered damage in DNA. Int J Radiat Biol (1994) 65(1):7-17. doi:10.1080/09553009414550021
16. Georgakilas AG, O'Neill P, Stewart RD. Induction and repair of clustered DNA lesions: what do we know so far? Radiat Res (2013) 180(1):100-9. doi:10.1667/RR3041.1
17. Sutherland BM, Georgakilas AG, Bennett PV, Laval J, Sutherland JC. Quantifying clustered DNA damage induction and repair by gel electrophoresis, electronic imaging and number average length analysis. Mutat Res (2003) 531(1-2):93-107. doi:10.1016/j.mrfmmm.2003.08.005
18. Sage E, Harrison L. Clustered DNA lesion repair in eukaryotes: relevance to mutagenesis and cell survival. Mutat Res (2011) 711(1-2):123-33. doi:10.1016/j.mrfmmm.2010.12.010
19. Zhou BB, Elledge SJ. The DNA damage response: putting checkpoints in perspective. Nature (2000) 408(6811):433-9. doi:10.1038/35044005
20. Khanna KK, Lavin MF, Jackson SP, Mulhern TD. ATM, a central controller of cellular responses to DNA damage. Cell Death Differ (2001) 8(11):1052-65. doi:10.1038/sj.cdd.4400874
21. Khanna KK, Jackson SP. DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet (2001) 27(3):247-54. doi:10.1038/85798
22. Shiloh Y, Ziv Y. The ATM protein kinase: regulating the cellular response to genotoxic stress, and more. Nat Rev Mol Cell Biol (2013) 14(4):197-210. doi:10.1038/nrm3546
23. Maynard S, Schurman SH, Harboe C, de Souza-Pinto NC, Bohr VA. Base excision repair of oxidative DNA damage and association with cancer and aging. Carcinogenesis (2009) 30(1):2-10. doi:10.1093/carcin/bgn250
24. Svilar D, Goellner EM, Almeida KH, Sobol RW. Base excision repair and lesion-dependent subpathways for repair of oxidative DNA damage. Antioxid Redox Signal (2011) 14(12):2491-507. doi:10.1089/ars.2010.3466
25. Jeggo PA, Geuting V, Lobrich M. The role of homologous recombination in radiation-induced double-strand break repair. Radiother Oncol (2011) 101(1):7-12. doi:10.1016/j.radonc.2011.06.019
26. Lieber MR. The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annu Rev Biochem (2010) 79:181-211. doi:10.1146/annurev.biochem.052308.093131
27. Puck TT, Marcus PI. Action of x-rays on mammalian cells. J Exp Med (1956) 103(5):653-66. doi:10.1084/jem.103.5.653
28. Vogin G, Foray N. The law of Bergonie and Tribondeau: a nice formula for a first approximation. Int J Radiat Biol (2013) 89(1):2-8. doi:10.3109/09553002.2012.717732
29. Lambert WC, Gagna CE, Lambert MW. Xeroderma pigmentosum: its overlap with trichothiodystrophy, Cockayne syndrome and other progeroid syndromes. Adv Exp Med Biol (2008) 637:128-37. doi:10.1007/978-0-387-09599-8_14
30. Jorgensen TJ, Shiloh Y. The ATM gene and the radiobiology of ataxia- telangiectasia. Int J Radiat Biol (1996) 69(5):527-37. doi:10.1080/095530096145535
31. Zhao S, Weng YC, Yuan SS, Lin YT, Hsu HC, Lin SC, et al. Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products. Nature (2000) 405(6785):473-7. doi:10.1038/35013083
32. Barendsen GW, Beusker TL, Vergroesen AJ, Budke L. Effects of different radiations on human cells in tissue culture. II. Biological experiments. Radiat Res (1960) 13:841-9. doi:10.2307/3570858
33. Barendsen GW, Walter HM, Fowler JF, Bewley DK. Effects of different ionizing radiations on human cells in tissue culture. III. Experiments with cyclotron-accelerated alpha-particles and deuterons. Radiat Res (1963) 18:106-19. doi:10.2307/3571430
34. Barendsen GW. Dose-survival curves of human cells in tissue culture irradiated with alpha-, beta-, 20-kV. x- and 200-kV. x-radiation. Nature (1962) 193:1153-5. doi:10.1038/1931153a0
35. Barendsen GW. Modification of radiation damage by fractionation of the dose, anoxia, and chemical protectors in relation to let. Ann N Y Acad Sci (1964) 114:96-114. doi:10.1111/j.1749-6632.1964.tb53565.x
36. Barendsen GW, Walter HM. Effects of different ionizing radiations on human cells in tissue culture. iv. Modification of radiation damage. Radiat Res (1964) 21:314-29. doi:10.2307/3571569
37. Deschavanne PJ, Malaise EP. The relevance of alpha/beta ratios determined in vitro for human cell lines to the understanding of in vivo values. Int J Radiat Biol (1989) 56(5):539-42. doi:10.1080/09553008914551701
38. Thames HD, Bentzen SM, Turesson I, Overgaard M, van den Bogaert W. Fractionation parameters for human tissues and tumors. Int J Radiat Biol (1989) 56(5):701-10. doi:10.1080/09553008914551931
39. De Ridder M, Jiang H, Van Esch G, Law K, Monsaert C, Van den Berge DL, et al. IFN-gamma+ CD8+ T lymphocytes: possible link between immune and radiation responses in tumor-relevant hypoxia. Int J Radiat Oncol Biol Phys (2008) 71(3):647-51. doi:10.1016/j.ijrobp.2008.03.014
40. Morgan GW, Breit SN. Radiation and the lung: a reevaluation of the mechanisms mediating pulmonary injury. Int J Radiat Oncol Biol Phys (1995) 31(2):361-9. doi:10.1016/0360-3016(94)00477-3
41. Calveley VL, Khan MA, Yeung IW, Vandyk J, Hill RP. Partial volume rat lung irradiation: temporal fluctuations of in-field and out-of-field DNA damage and inflammatory cytokines following irradiation. Int J Radiat Biol (2005) 81(12):887-99. doi:10.1080/09553000600568002
42. Shao C, Folkard M, Michael BD, Prise KM. Bystander signaling between glioma cells and fibroblasts targeted with counted particles. Int J Cancer (2005) 116(1):45-51. doi:10.1002/ijc.21003
43. Murphy JB, Liu JH, Sturm E. Studies on X-ray effects: Ix. The action of serum from X-rayed animals on lymphoid cells in vitro. J Exp Med (1922) 35(3):373-84. doi:10.1084/jem.35.3.373
44. Mole RH. Whole body irradiation; radiobiology or medicine? Br J Radiol (1953) 26(305):234-41. doi:10.1259/0007-1285-26-305-234
45. Hollowell JG Jr, Littlefield LG. Chromosome damage induced by plasma of x-rayed patients: an indirect effect of x-ray. Proc Soc Exp Biol Med (1968) 129(1):240-4. doi:10.3181/00379727-129-33295
46. Emerit I, Levy A, Cernjavski L, Arutyunyan R, Oganesyan N, Pogosian A, et al. Transferable clastogenic activity in plasma from persons exposed as salvage personnel of the Chernobyl reactor. J Cancer Res Clin Oncol (1994) 120(9):558-61. doi:10.1007/BF01221035
47. Nagasawa H, Little JB. Induction of sister chromatid exchanges by extremely low doses of alpha-particles. Cancer Res (1992) 52(22):6394-6.
48. Demaria S, Ng B, Devitt ML, Babb JS, Kawashima N, Liebes L, et al. Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated. Int J Radiat Oncol Biol Phys (2004) 58(3):862-70. doi:10.1016/j.ijrobp.2003.09.012
49. Demaria S, Formenti SC. Role of T lymphocytes in tumor response to radiotherapy. Front Oncol (2012) 2:95. doi:10.3389/fonc.2012.00095
50. Prise KM, O'Sullivan JM. Radiation-induced bystander signalling in cancer therapy. Nat Rev Cancer (2009) 9(5):351-60. doi:10.1038/nrc2603
51. Lee Y, Auh SL, Wang Y, Burnette B, Wang Y, Meng Y, et al. Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment. Blood (2009) 114(3):589-95. doi:10.1182/blood-2009-02-206870
52. Havaki S, Kotsinas A, Chronopoulos E, Kletsas D, Georgakilas A, Gorgoulis VG. The role of oxidative DNA damage in radiation induced bystander effect. Cancer Lett (2015) 356(1):43-51. doi:10.1016/j.canlet.2014.01.023
53. Andarawewa KL, Paupert J, Pal A, Barcellos-Hoff MH. New rationales for using TGFbeta inhibitors in radiotherapy. Int J Radiat Biol (2007) 83(11-12):803-11. doi:10.1080/09553000701711063
54. Lee H, Herrmann A, Deng JH, Kujawski M, Niu G, Li Z, et al. Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors. Cancer Cell (2009) 15(4):283-93. doi:10.1016/j.ccr.2009.02.015
55. Grivennikov SI, Karin M. Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev (2010) 21(1):11-9. doi:10.1016/j.cytogfr.2009.11.005
56. Burdak-Rothkamm S, Rothkamm K, Prise KM. ATM acts downstream of ATR in the DNA damage response signaling of bystander cells. Cancer Res (2008) 68(17):7059-65. doi:10.1158/0008-5472.CAN-08-0545
57. Alper T. Effects on irradiated micro-organisms of growth in the presence of acriflavine. Nature (1963) 200:534-6. doi:10.1038/200534a0
58. Hussain SP, Hofseth LJ, Harris CC. Radical causes of cancer. Nat Rev Cancer (2003) 3(4):276-85. doi:10.1038/nrc1046
59. Corre I, Niaudet C, Paris F. Plasma membrane signaling induced by ionizing radiation. Mutat Res (2010) 704(1-3):61-7. doi:10.1016/j.mrrev.2010.01.014
60. Kolesnick RN, Haimovitz-Friedman A, Fuks Z. The sphingomyelin signal transduction pathway mediates apoptosis for tumor necrosis factor, Fas, and ionizing radiation. Biochem Cell Biol (1994) 72(11-12):471-4. doi:10.1139/o94-063
61. Haimovitz-Friedman A, Kan CC, Ehleiter D, Persaud RS, McLoughlin M, Fuks Z, et al. Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J Exp Med (1994) 180(2):525-35. doi:10.1084/jem.180.2.525
62. Haimovitz-Friedman A, Balaban N, McLoughlin M, Ehleiter D, Michaeli J, Vlodavsky I, et al. Protein kinase C mediates basic fibroblast growth factor protection of endothelial cells against radiation-induced apoptosis. Cancer Res (1994) 54(10):2591-7.
63. Poyton RO, Ball KA, Castello PR. Mitochondrial generation of free radicals and hypoxic signaling. Trends Endocrinol Metab (2009) 20(7):332-40. doi:10.1016/j.tem.2009.04.001
64. Murphy JE, Nugent S, Seymour C, Mothersill C. Mitochondrial DNA point mutations and a novel deletion induced by direct low-LET radiation and by medium from irradiated cells. Mutat Res (2005) 585(1-2):127-36. doi:10.1016/j.mrgentox.2005.04.011
65. Druzhyna NM, Wilson GL, LeDoux SP. Mitochondrial DNA repair in aging and disease. Mech Ageing Dev (2008) 129(7-8):383-90. doi:10.1016/j.mad.2008.03.002
66. Graziewicz MA, Day BJ, Copeland WC. The mitochondrial DNA polymerase as a target of oxidative damage. Nucleic Acids Res (2002) 30(13):2817-24. doi:10.1093/nar/gkf392
67. Prithivirajsingh S, Story MD, Bergh SA, Geara FB, Ang KK, Ismail SM, et al. Accumulation of the common mitochondrial DNA deletion induced by ionizing radiation. FEBS Lett (2004) 571(1-3):227-32. doi:10.1016/j.febslet.2004.06.078
68. Bodet-Milin C, Ferrer L, Pallardy A, Eugène T, Rauscher A, Faivre-Chauvet A, et al. Radioimmunotherapy of B-cell non-Hodgkin's lymphoma. Front Oncol (2013) 3:177. doi:10.3389/fonc.2013.00177
69. Kaminski MS, Tuck M, Estes J, Kolstad A, Ross CW, Zasadny K, et al. 131I-tositumomab therapy as initial treatment for follicular lymphoma. N Engl J Med (2005) 352(5):441-9. doi:10.1056/NEJMoa041511
70. Pouget JP, Navarro-Teulon I, Bardiès M, Chouin N, Cartron G, Pèlegrin A, et al. Clinical radioimmunotherapy - the role of radiobiology. Nat Rev Clin Oncol (2011) 8(12):720-34. doi:10.1038/nrclinonc.2011.160
71. DeNardo SJ, Denardo GL. Targeted radionuclide therapy for solid tumors: an overview. Int J Radiat Oncol Biol Phys (2006) 66(2 Suppl):S89-95. doi:10.1016/j.ijrobp.2006.03.066
72. Navarro-Teulon I, Lozza C, Pèlegrin A, Vivès E, Pouget JP. General overview of radioimmunotherapy of solid tumors. Immunotherapy (2013) 5(5):467-87. doi:10.2217/imt.13.34
73. Sharkey RM, Goldenberg DM. Cancer radioimmunotherapy. Immunotherapy (2011) 3(3):349-70. doi:10.2217/imt.10.114
74. Chouin N, Bernardeau K, Bardiès M, Faivre-Chauvet A, Bourgeois M, Apostolidis C, et al. Evidence of extranuclear cell sensitivity to alpha-particle radiation using a microdosimetric model. II. Application of the microdosimetric model to experimental results. Radiat Res (2009) 171(6):664-73. doi:10.1667/RR1536.1
75. Chouin N, Bernardeau K, Davodeau F, Chérel M, Faivre-Chauvet A, Bourgeois M, et al. Evidence of extranuclear cell sensitivity to alpha-particle radiation using a microdosimetric model. I. Presentation and validation of a microdosimetric model. Radiat Res (2009) 171(6):657-63. doi:10.1667/RR1371.1
76. Pouget JP, Santoro L, Raymond L, Chouin N, Bardiès M, Bascoul-Mollevi C, et al. Cell membrane is a more sensitive target than cytoplasm to dense ionization produced by auger electrons. Radiat Res (2008) 170(2):192-200. doi:10.1667/RR1359.1
77. Freudenberg R, Runge R, Maucksch U, Berger V, Kotzerke J. On the dose calculation at the cellular level and its implications for the RBE of (99m)Tc and (1)(2)(3)I. Med Phys (2014) 41(6):062503. doi:10.1118/1.4876296
78. Piron B, Paillas S, Boudousq V, Pèlegrin A, Bascoul-Mollevi C, Chouin N, et al. DNA damage-centered signaling pathways are effectively activated during low dose-rate auger radioimmunotherapy. Nucl Med Biol (2014) 41(Suppl):e75-83. doi:10.1016/j.nucmedbio.2014.01.012
79. Bolch WE, Eckerman KF, Sgouros G, Thomas SR. MIRD pamphlet No. 21: a generalized schema for radiopharmaceutical dosimetry - standardization of nomenclature. J Nucl Med (2009) 50(3):477-84. doi:10.2967/jnumed.108.056036
80. Neti PV, Howell RW. Log normal distribution of cellular uptake of radioactivity: implications for biologic responses to radiopharmaceuticals. J Nucl Med (2006) 47(6):1049-58.
81. Back T, Jacobsson L. The alpha-camera: a quantitative digital autoradiography technique using a charge-coupled device for ex vivo high-resolution bioimaging of alpha-particles. J Nucl Med (2010) 51(10):1616-23. doi:10.2967/jnumed.110.077578
82. Ritt P, Vija H, Hornegger J, Kuwert T. Absolute quantification in SPECT. Eur J Nucl Med Mol Imaging (2011) 38(Suppl 1):S69-77. doi:10.1007/s00259-011-1770-8
83. Tornai MP, Jaszczak RJ, Turkington TG, Coleman RE, et al. Small-animal PET: advent of a new era of PET research. J Nucl Med (1999) 40(7):1176-9.
84. Lassmann M, Chiesa C, Flux G, Bardiès M, EANM Dosimetry Committee. EANM dosimetry committee guidance document: good practice of clinical dosimetry reporting. Eur J Nucl Med Mol Imaging (2011) 38(1):192-200. doi:10.1007/s00259-010-1549-3
85. Stabin MG, Peterson TE, Holburn GE, Emmons MA, et al. Voxel-based mouse and rat models for internal dose calculations. J Nucl Med (2006) 47(4):655-9.
86. Bitar A, Lisbona A, Thedrez P, Sai Maurel C, Le Forestier D, Barbet J, et al. A voxel-based mouse for internal dose calculations using Monte Carlo simulations (MCNP). Phys Med Biol (2007) 52(4):1013-25. doi:10.1088/0031-9155/52/4/010
87. Goddu SM, Howell RW, Bouchet LG, Bolch WE, Rao DV. MIRD Cellular S Values: Self-Absorbed Dose Per Unit Cumulated Activity for Selected Radionuclides and Monoenergetic Electron and Alpha Particle Emitters Incorporated into Different Cell Compartments. Reston, VA: Society of Nuclear Medicine (1997).
88. Boutaleb S, Pouget JP, Hindorf C, Pelegrin A, Barbet J, Kotzki PO, et al. Impact of mouse model on pre-clinical dosimetry in targeted radionuclide therapy. Proc IEEE (2009) 87:2076-85. doi:10.1109/JPROC.2009.2026921
89. Flux GD, Haq M, Chittenden SJ, Buckley S, Hindorf C, Newbold K, et al. A dose-effect correlation for radioiodine ablation in differentiated thyroid cancer. Eur J Nucl Med Mol Imaging (2010) 37(2):270-5. doi:10.1007/s00259-009-1261-3
90. Dewaraja YK, Schipper MJ, Shen J, Smith LB, Murgic J, Savas H, et al. Tumor-absorbed dose predicts progression-free survival following 131I-tositumomab radioimmunotherapy. J Nucl Med (2014) 55(7):1047-53. doi:10.2967/jnumed.113.136044
91. Dewaraja YK, Schipper MJ, Roberson PL, Wilderman SJ, Amro H, Regan DD, et al. 131I-tositumomab radioimmunotherapy: initial tumor dose-response results using 3-dimensional dosimetry including radiobiologic modeling. J Nucl Med (2010) 51(7):1155-62. doi:10.2967/jnumed.110.075176
92. Strigari L, Konijnenberg M, Chiesa C, Bardies M, Du Y, Gleisner KS, et al. The evidence base for the use of internal dosimetry in the clinical practice of molecular radiotherapy. Eur J Nucl Med Mol Imaging (2014) 41:1976-88. doi:10.1007/s00259-014-2824-5
93. Sgouros G, Squeri S, Ballangrud AM, Kolbert KS, Teitcher JB, Panageas KS, et al. Patient-specific, 3-dimensional dosimetry in non-Hodgkin's lymphoma patients treated with 131I-anti-B1 antibody: assessment of tumor dose-response. J Nucl Med (2003) 44(2):260-8.
94. Wessels BW, Konijnenberg MW, Dale RG, Breitz HB, Cremonesi M, Meredith RF, et al. MIRD pamphlet No. 20: the effect of model assumptions on kidney dosimetry and response - implications for radionuclide therapy. J Nucl Med (2008) 49(11):1884-99. doi:10.2967/jnumed.108.053173
95. Wessels BW, Vessella RL, Palme DF II, Berkopec JM, Smith GK, Bradley EW. Radiobiological comparison of external beam irradiation and radioimmunotherapy in renal cell carcinoma xenografts. Int J Radiat Oncol Biol Phys (1989) 17(6):1257-63. doi:10.1016/0360-3016(89)90534-8
96. Ning S, Knox SJ. G2/M-phase arrest and death by apoptosis of HL60 cells irradiated with exponentially decreasing low-dose-rate gamma radiation. Radiat Res (1999) 151(6):659-69. doi:10.2307/3580204
97. Sgouros G, Knox SJ, Joiner MC, Morgan WF, Kassis AI. MIRD continuing education: bystander and low dose-rate effects: are these relevant to radionuclide therapy? J Nucl Med (2007) 48(10):1683-91. doi:10.2967/jnumed.105.028183
98. Knox SJ, Goris ML, Wessels BW. Overview of animal studies comparing radioimmunotherapy with dose equivalent external beam irradiation. Radiother Oncol (1992) 23(2):111-7. doi:10.1016/0167-8140(92)90342-R
99. Knox SJ, Sutherland W, Goris ML. Correlation of tumor sensitivity to low-dose-rate irradiation with G2/M-phase block and other radiobiological parameters. Radiat Res (1993) 135(1):24-31. doi:10.2307/3578392
100. Fowler JF. Radiobiological aspects of low dose rates in radioimmunotherapy. Int J Radiat Oncol Biol Phys (1990) 18(5):1261-9. doi:10.1016/0360-3016(90)90467-X
101. Murtha AD. Radiobiology of low-dose-rate radiation relevant to radioimmunotherapy. Cancer Biother Radiopharm (2000) 15(1):7-14. doi:10.1089/cbr.2000.15.7
102. Murtha AD. Review of low-dose-rate radiobiology for clinicians. Semin Radiat Oncol (2000) 10(2):133-8. doi:10.1016/S1053-4296(00)80050-8
103. Brady D, O'Sullivan JM, Prise KM. What is the role of the bystander response in radionuclide therapies? Front Oncol (2013) 3:215. doi:10.3389/fonc.2013.00215
104. Prise KM, Schettino G, Folkard M, Held KD. New insights on cell death from radiation exposure. Lancet Oncol (2005) 6(7):520-8. doi:10.1016/S1470-2045(05)70246-1
105. Boyd M, Ross SC, Dorrens J, Fullerton NE, Tan KW, Zalutsky MR, et al. Radiation-induced biologic bystander effect elicited in vitro by targeted radiopharmaceuticals labeled with alpha-, beta-, and auger electron-emitting radionuclides. J Nucl Med (2006) 47(6):1007-15.
106. Paillas S, Boudousq V, Piron B, Kersual N, Bardiès M, Chouin N, et al. Apoptosis and p53 are not involved in the anti-tumor efficacy of (1)(2)(5)I-labeled monoclonal antibodies targeting the cell membrane. Nucl Med Biol (2013) 40(4):471-80. doi:10.1016/j.nucmedbio.2013.02.001
107. Boyd M, Sorensen A, McCluskey AG, Mairs RJ. Radiation quality-dependent bystander effects elicited by targeted radionuclides. J Pharm Pharmacol (2008) 60(8):951-8. doi:10.1211/jpp.60.8.0002
108. Bishayee A, Rao DV, Howell RW. Evidence for pronounced bystander effects caused by nonuniform distributions of radioactivity using a novel three-dimensional tissue culture model. Radiat Res (1999) 152(1):88-97. doi:10.2307/3580054